Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Human milk oligosaccharides: the novel modulator of intestinal microbiota.

Jeong K, Nguyen V, Kim J.

BMB Rep. 2012 Aug;45(8):433-41. doi: 10.5483/BMBRep.2012.45.8.168. Review.

2.

Do oral probiotics affect growth and neurodevelopmental outcomes in very low-birth-weight preterm infants?

Sari FN, Eras Z, Dizdar EA, Erdeve O, Oguz SS, Uras N, Dilmen U.

Am J Perinatol. 2012 Sep;29(8):579-86. doi: 10.1055/s-0032-1311981. Epub 2012 May 7.

PMID:
22566113
3.

Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis.

Fernández-Carrocera LA, Solis-Herrera A, Cabanillas-Ayón M, Gallardo-Sarmiento RB, García-Pérez CS, Montaño-Rodríguez R, Echániz-Aviles MO.

Arch Dis Child Fetal Neonatal Ed. 2013 Jan;98(1):F5-9. doi: 10.1136/archdischild-2011-300435. Epub 2012 May 3.

PMID:
22556209
4.

Strategies for prevention of health care-associated infections in the NICU.

Polin RA, Denson S, Brady MT; Committee on Fetus and Newborn.; Committee on Infectious Diseases..

Pediatrics. 2012 Apr;129(4):e1085-93. doi: 10.1542/peds.2012-0145. Epub 2012 Mar 26. Review.

PMID:
22451712
5.
6.

Choice and duration of antimicrobial therapy for neonatal sepsis and meningitis.

Sivanandan S, Soraisham AS, Swarnam K.

Int J Pediatr. 2011;2011:712150. doi: 10.1155/2011/712150. Epub 2011 Nov 20.

7.

Bifidobacterium septicaemia in an extremely low-birthweight infant under probiotic therapy.

Jenke A, Ruf EM, Hoppe T, Heldmann M, Wirth S.

Arch Dis Child Fetal Neonatal Ed. 2012 May;97(3):F217-8. doi: 10.1136/archdischild-2011-300838. Epub 2011 Nov 4. No abstract available.

PMID:
22058179
8.

Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants.

Mihatsch WA, Braegger CP, Decsi T, Kolacek S, Lanzinger H, Mayer B, Moreno LA, Pohlandt F, Puntis J, Shamir R, Stadtmüller U, Szajewska H, Turck D, van Goudoever JB.

Clin Nutr. 2012 Feb;31(1):6-15. doi: 10.1016/j.clnu.2011.09.004. Epub 2011 Oct 13. Review.

PMID:
21996513
9.

Lactobacillus rhamnosus administration causes sepsis in a cardiosurgical patient--is the time right to revise probiotic safety guidelines?

Kochan P, Chmielarczyk A, Szymaniak L, Brykczynski M, Galant K, Zych A, Pakosz K, Giedrys-Kalemba S, Lenouvel E, Heczko PB.

Clin Microbiol Infect. 2011 Oct;17(10):1589-92. doi: 10.1111/j.1469-0691.2011.03614.x. Epub 2011 Aug 16.

10.

The ProPrems trial: investigating the effects of probiotics on late onset sepsis in very preterm infants.

Garland SM, Tobin JM, Pirotta M, Tabrizi SN, Opie G, Donath S, Tang ML, Morley CJ, Hickey L, Ung L, Jacobs SE; ProPrems Study Group..

BMC Infect Dis. 2011 Aug 4;11:210. doi: 10.1186/1471-2334-11-210.

11.

Impact of sepsis on neurodevelopmental outcome in a Swiss National Cohort of extremely premature infants.

Schlapbach LJ, Aebischer M, Adams M, Natalucci G, Bonhoeffer J, Latzin P, Nelle M, Bucher HU, Latal B; Swiss Neonatal Network and Follow-Up Group..

Pediatrics. 2011 Aug;128(2):e348-57. doi: 10.1542/peds.2010-3338. Epub 2011 Jul 18.

PMID:
21768312
12.

New possibilities of prevention of infection in the newborn.

Borghesi A, Tzialla C, Decembrino L, Manzoni P, Stronati M.

J Matern Fetal Neonatal Med. 2011 Oct;24 Suppl 2:28-30. doi: 10.3109/14767058.2011.604934. Review.

PMID:
21749301
13.

Probiotic sepsis due to Saccharomyces fungaemia in a critically ill burn patient.

Stefanatou E, Kompoti M, Paridou A, Koutsodimitropoulos I, Giannopoulou P, Markou N, Kalofonou M, Trikka-Graphakos E, Tsidemiadou F.

Mycoses. 2011 Sep;54(5):e643-6. doi: 10.1111/j.1439-0507.2010.01963.x. Epub 2011 Jun 14. No abstract available.

PMID:
21672040
14.

Probiotics for prevention of necrotizing enterocolitis in preterm infants.

Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD005496. doi: 10.1002/14651858.CD005496.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;4:CD005496.

PMID:
21412889
15.

Recent advances in prevention of sepsis in the premature neonates in NICU.

Manzoni P, Rizzollo S, Decembrino L, Ruffinazzi G, Rossi Ricci A, Gallo E, Stolfi I, Mostert M, Stronati M, Farina D.

Early Hum Dev. 2011 Mar;87 Suppl 1:S31-3. doi: 10.1016/j.earlhumdev.2011.01.008. Epub 2011 Jan 19. Review.

PMID:
21251768
16.

Necrotizing enterocolitis.

Neu J, Walker WA.

N Engl J Med. 2011 Jan 20;364(3):255-64. doi: 10.1056/NEJMra1005408. Review. No abstract available.

17.

Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial.

Sari FN, Dizdar EA, Oguz S, Erdeve O, Uras N, Dilmen U.

Eur J Clin Nutr. 2011 Apr;65(4):434-9. doi: 10.1038/ejcn.2010.278. Epub 2011 Jan 19.

PMID:
21245887
18.

Probiotics and prebiotics in pediatrics.

Thomas DW, Greer FR; American Academy of Pediatrics Committee on Nutrition.; American Academy of Pediatrics Section on Gastroenterology, Hepatology, and Nutrition..

Pediatrics. 2010 Dec;126(6):1217-31. doi: 10.1542/peds.2010-2548. Epub 2010 Nov 29. Review.

PMID:
21115585
19.

Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial.

Braga TD, da Silva GA, de Lira PI, de Carvalho Lima M.

Am J Clin Nutr. 2011 Jan;93(1):81-6. doi: 10.3945/ajcn.2010.29799. Epub 2010 Oct 27.

20.

Comparison between killed and living probiotic usage versus placebo for the prevention of necrotizing enterocolitis and sepsis in neonates.

Awad H, Mokhtar H, Imam SS, Gad GI, Hafez H, Aboushady N.

Pak J Biol Sci. 2010 Mar 15;13(6):253-62.

PMID:
20506712

Supplemental Content

Support Center